Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.38B |
| 2 |
Microsoft
MSFT
|
+$1.13B |
| 3 |
Amazon
AMZN
|
+$756M |
| 4 |
Tesla
TSLA
|
+$466M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
XLNX
Xilinx Inc
XLNX
|
+$199M |
| 2 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$191M |
| 3 |
NUAN
Nuance Communications, Inc.
NUAN
|
+$62.8M |
| 4 |
KL
Kirkland Lake Gold Ltd Ordinary
KL
|
+$43.9M |
| 5 |
ATH
Athene Holding Ltd. Class A Common Shares
ATH
|
+$42.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.22% |
| 2 | Healthcare | 14.23% |
| 3 | Consumer Discretionary | 13.07% |
| 4 | Communication Services | 9.53% |
| 5 | Industrials | 8.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SLCA
1726
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $3.29M | ﹤0.01% |
176,300
+12,500
| +8% | +$158K |
|
1727
Cerence
CRNC
$389M
| $3.29M | ﹤0.01% |
91,050
+7,400
| +9% | +$364K |
|
|
ADAM
1728
Adamas Trust
ADAM
$907M
| $3.27M | ﹤0.01% |
224,230
+14,775
| +7% | +$216K |
|
|
GCP
1729
DELISTED
GCP Applied Technologies Inc.
GCP
| $3.27M | ﹤0.01% |
104,200
+7,600
| +8% | +$241K |
|
1730
Healthcare Services Group
HCSG
$1.45B
| $3.27M | ﹤0.01% |
176,263
+11,600
| +7% | +$200K |
|
1731
Enova International
ENVA
$6.52B
| $3.27M | ﹤0.01% |
86,100
+4,900
| +6% | +$197K |
|
1732
Sinclair Inc
SBGI
$1.03B
| $3.26M | ﹤0.01% |
116,250
+8,100
| +7% | +$225K |
|
1733
TriMas Corp
TRS
$1.39B
| $3.25M | ﹤0.01% |
101,300
+6,900
| +7% | +$230K |
|
1734
Amphastar Pharmaceuticals
AMPH
$858M
| $3.25M | ﹤0.01% |
90,500
+6,700
| +8% | +$190K |
|
1735
Veeco
VECO
$3.28B
| $3.25M | ﹤0.01% |
119,421
+8,600
| +8% | +$242K |
|
1736
Array Technologies
ARRY
$796M
| $3.24M | ﹤0.01% |
287,300
+35,400
| +14% | +$398K |
|
|
SILK
1737
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $3.24M | ﹤0.01% |
78,400
+6,000
| +8% | +$211K |
|
1738
Valaris
VAL
$5.91B
| $3.23M | ﹤0.01% |
62,100
+4,300
| +7% | +$186K |
|
1739
Aurinia Pharmaceuticals
AUPH
$2.02B
| $3.23M | ﹤0.01% |
260,600
+20,400
| +8% | +$315K |
|
1740
8x8 Inc
EGHT
$303M
| $3.22M | ﹤0.01% |
255,900
+21,700
| +9% | +$301K |
|
1741
Safety Insurance
SAFT
$1.52B
| $3.22M | ﹤0.01% |
35,400
+2,300
| +7% | +$196K |
|
1742
Patrick Industries
PATK
$2.78B
| $3.21M | ﹤0.01% |
79,763
+5,550
| +7% | +$256K |
|
1743
Green Dot
GDOT
$770M
| $3.2M | ﹤0.01% |
116,300
+8,100
| +7% | +$246K |
|
|
ISEE
1744
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $3.19M | ﹤0.01% |
189,800
+29,700
| +19% | +$439K |
|
|
RDUS
1745
DELISTED
Radius Recycling
RDUS
| $3.19M | ﹤0.01% |
61,400
+4,300
| +8% | +$194K |
|
1746
CoreCivic
CXW
$3.13B
| $3.18M | ﹤0.01% |
284,418
+18,600
| +7% | +$182K |
|
|
LADR
1747
Ladder Capital
LADR
$1.27B
| $3.17M | ﹤0.01% |
266,907
+15,600
| +6% | +$183K |
|
1748
First Busey Corp
BUSE
$2.58B
| $3.17M | ﹤0.01% |
124,999
+7,300
| +6% | +$201K |
|
1749
Mesa Laboratories
MLAB
$633M
| $3.16M | ﹤0.01% |
12,402
+900
| +8% | +$244K |
|
1750
Stock Yards Bancorp
SYBT
$2.64B
| $3.16M | ﹤0.01% |
59,723
+4,200
| +8% | +$241K |
|
Similar funds
Swiss National Bank's Q1 2022 Portfolio in Review
As of Q1 2022, Swiss National Bank held 2,722 positions worth $177B, up 6.8% from $166B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Swiss National Bank deployed $20.2B of net new capital in Q1 2022, opening 3 new positions and adding to 2,642 existing holdings. Its largest new stake was Constellation Energy: 1,411,783 shares worth $79.4M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 29% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Exelon, an estimated $41.2M trimmed.
- Swiss National Bank's largest Q1 2022 buy was Constellation Energy: 1,411,783 shares worth $79.4M.
- Swiss National Bank added most to Apple in Q1 2022, an estimated $1.38B increase.
- Swiss National Bank's biggest Q1 2022 reduction was Exelon, cutting an estimated $41.2M.
- Swiss National Bank fully exited Xilinx Inc in Q1 2022, selling an estimated $199M.
- Swiss National Bank's ten largest holdings make up 28% of its $177B portfolio in Q1 2022.
- Swiss National Bank opened 3 new positions and closed 31 in Q1 2022.
- Swiss National Bank's portfolio value rose 6.8% quarter-over-quarter to $177B.
Based on Swiss National Bank's 13F filing for Q1 2022, filed 9 May 2022.